Evidence map›Paper›PMID 38720474›Full record

ArticleCancer science2024

Dysfunction of CD8

Chaozhuo Li, Mengyu Hu, Siqi Cai, Guanqun Yang, Liying Yang, Hongbiao Jing, Ligang Xing, Xiaorong Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Closer proximity of pre-treatment CD4Translational lung cancer research · 2025
    Article
  3. Article
  4. Dysfunction of CD8Cancer science · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chaozhuo LiSchool of Clinical Medicine, Shandong Second Medical University, Weifang, China.
Mengyu HuDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Siqi CaiDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Guanqun YangDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Liying YangDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Hongbiao JingDepartment of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Ligang XingDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Xiaorong SunDepartment of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.ORCID https://orcid.org/0000-0001-8520-9556

Funding

Department of Science and Technology of Shandong Province 2021CXGC011102National Natural Science Foundation of China 82172866National Natural Science Foundation of China 82373424Natural Science Foundation of Shandong Province ZR2021LZL005
6 · The paper itself

Abstract

Occult lymph node metastasis (OLNM) is one of the main causes of regional recurrence in inoperable N

Indexed as

Carcinoma, Non-Small-Cell LungCD8-Positive T-LymphocytesLung NeoplasmsLymphatic MetastasisAgedFemaleHumansHypoxia-Inducible Factor 1, alpha SubunitLymph NodesMaleMiddle AgedTumor MicroenvironmentHypoxia-Inducible Factor 1, alpha SubunitCD8+ T celldysfunctionnon‐small cell lung canceroccult lymph node metastasistumor immune microenvironment

Identifiers

PMID38720474
PMCPMC11309950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.